Brian E. Grottkau

Dr. Brian E. Grottkau


Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2011 in Biology of the Cell
Verified
Journal Article
Open access
PDF file
Xiaoxiao CaiXiaoxiao Cai
Xiaoxiao Cai
YLYunfeng Lin
Yunfeng Lin
PHPeter V. Hauschka
Peter V. Hauschka
BGBrian E. Grottkau
Brian E. Grottkau
Recent research has shown that adipose tissues contain abundant MSCs (mesenchymal stem cells). The origin and location of the adipose stem cells, however, remain unknown, presenting an obstacle to the further purification and study of these cells. In the present study, we aimed at investigating the origins of adipose stem cells. α‐SMA (α‐smooth muscle actin) is one of the markers of pericytes. We harvested ASCs (adipose stromal cells) from α‐SMA‐GFP (green fluorescent protein) transgenic mice and sorted them into GFP‐positive and GFP‐negative cells by FACS. Multilineage differentiation tests were applied to examine the pluripotent ability of the α‐SMA‐GFP‐positive and ‐negative cells. Immunofluorescent staining for α‐SMA and PDGF‐Rβ (platelet‐derived growth factor receptor β) were applied to identify the α‐SMA‐GFP‐positive cells. Then α‐SMA‐GFP‐positive cells were loaded on a collagen—fibronectin gel with endothelial cells to test their vascularization ability both in vitro and in vivo. Results show that, in adipose tissue, all of the α‐SMA‐GFP‐positive cells congregate around the blood vessels. Only the α‐SMA‐GFP‐positive cells have multilineage differentiation ability, while the α‐SMA‐GFP‐negative cells can only differentiate in an adipogenic direction. The α‐SMA‐GFP‐positive cells maintained expression of α‐SMA during multilineage differentiation. The α‐SMA‐GFP‐positive cells can promote the vascularization of endothelial cells in three‐dimensional culture both in vitro and in vivo. We conclude that the adipose stem cells originate from perivascular cells and congregate around blood vessels.

26 February 2010 in Cell Proliferation
Verified
Journal Article
Closed access
PDF file
YHY. Huang
Y. Huang
XYX. Yang
X. Yang
YWY. Wu
Y. Wu
WJW. Jing
W. Jing
Xiaoxiao CaiXiaoxiao Cai
Xiaoxiao Cai
YLY. Lin
Y. Lin

2 October 2009 in Stem Cell Reviews and Reports
Verified
Journal Article
Closed access
PDF file
Xiaoxiao CaiXiaoxiao Cai
Xiaoxiao Cai
YLYunfeng Lin
Yunfeng Lin
CFClaudia C. Friedrich
Claudia C. Friedrich
CNCraig Neville
Craig Neville
IPIrina Pomerantseva
Irina Pomerantseva
BGBrian E. Grottkau
Brian E. Grottkau

Verified
Journal Article
Open access
PDF file
BGBrian E. Grottkau
Brian E. Grottkau
ZHZhixin Hui
Zhixin Hui
YYYang Yao
Yang Yao
YPYonggang Pang
Yonggang Pang
Fused deposit modeling (FDM) 3D printing technology cannot generate scaffolds with high porosity while maintaining good integrity, anatomical-surface detail, or high surface area-to-volume ratio (S/V). Solvent casting and particulate leaching (SCPL) technique generates scaffolds with high porosity and high S/V. However, it is challenging to generate complex-shaped scaffolds; and solvent, particle and residual water removal are time consuming. Here we report techniques surmounting these problems, successfully generating a highly porous scaffold with the anatomical-shape characteristics of a human femur by polylactic acid polymer (PLA) and PLA-hydroxyapatite (HA) casting and salt leaching. The mold is water soluble and is easily removable. By perfusing with ethanol, water, and dry air sequentially, the solvent, salt, and residual water were removed 20 fold faster than utilizing conventional methods. The porosities are uniform throughout the femoral shaped scaffold generated with PLA or PLA-HA. Both scaffolds demonstrated good biocompatibility with the pre-osteoblasts (MC3T3-E1) fully attaching to the scaffold within 8 h. The cells demonstrated high viability and proliferation throughout the entire time course. The HA-incorporated scaffolds demonstrated significantly higher compressive strength, modulus and osteoinductivity as evidenced by higher levels of alkaline-phosphatase activity and calcium deposition. When 3D printing a 3D model at 95% porosity or above, our technology preserves integrity and surface detail when compared with FDM-generated scaffolds. Our technology can also generate scaffolds with a 31 fold larger S/V than FDM. We have developed a technology that is a versatile tool in creating personalized, patient-specific bone graft scaffolds efficiently with high porosity, good scaffold integrity, high anatomical-shaped surface detail and large S/V.

Verified
Journal Article
Open access
PDF file
BGBrian E. Grottkau
Brian E. Grottkau
ZHZhixin Hui
Zhixin Hui
YPYonggang Pang
Yonggang Pang
Drop-on-demand (DOD) 3D bioprinting technologies currently hold the greatest promise for generating functional tissues for clinical use and for drug development. However, existing DOD 3D bioprinting technologies have three main limitations: (1) droplet volume inconsistency; (2) the ability to print only bioinks with low cell concentrations and low viscosity; and (3) problems with cell viability when dispensed under high pressure. We report our success developing a novel direct-volumetric DOD (DVDOD) 3D bioprinting technology that overcomes each of these limitations. DVDOD can produce droplets of bioink from <10 nL in volume using a direct-volumetric mechanism with <± 5% volumetric percent accuracy in an accurate spatially controlled manner. DVDOD has the capability of dispensing bioinks with high concentrations of cells and/or high viscosity biomaterials in either low- or high-throughput modes. The cells are subjected to a low pressure during the bioprinting process for a very short period of time that does not negatively impact cell viability. We demonstrated the functions of the bioprinter in two distinct manners: (1) by using a high-throughput drug-delivery model; and (2) by bioprinting micro-tissues using a variety of different cell types, including functional micro-tissues of bone, cancer, and induced pluripotent stem cells. Our DVDOD technology demonstrates a promising platform for generating many types of tissues and drug-delivery models.

8 September 2010 in Journal of Tissue Engineering and Regenerative Medicine
Verified
Journal Article
Closed access
PDF file
Xiaoxiao CaiXiaoxiao Cai
Xiaoxiao Cai
YZYi Zhang
Yi Zhang
XYXingmei Yang
Xingmei Yang
BGBrian E. Grottkau
Brian E. Grottkau
YLYunfeng Lin
Yunfeng Lin
As the most important organs of occlusion, teeth are subjected to a variety of mechanical stresses. These stresses are transmitted into the dental pulp tissue and affect the dental pulp stem cells. In this study, human dental pulp stem cells were isolated from human impacted third molars and their multilineage differentiation abilities were tested. Human dental pulp stem cells were then exposed to cyclic tensile stretch. The results showed that the cyclic tensile stretch inhibited the expression of osteogenic marker genes and proteins such as BMP‐2, OCN and ALP. Simultaneously, odontogenic marker genes and proteins such as DSPP, DSP and BSP were also inhibited by the mechanical stress. It was concluded that cyclic tensile stretch inhibits the osteogenic and odontogenic differentiation of dental pulp stem cells. Copyright © 2010 John Wiley & Sons, Ltd.